Birdwatch Note
2024-08-17 14:14:09 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Contexto: Harris promete quitarles las patentes a las compañías farmacéuticas que recibieron fondos federales para I+D de un medicamento protegido por patente y se niegen a reducir su precio en Estados Unidos. https://www.c-span.org/video/?466668-1/kamala-harris-meets-voters-muscatine-iowa el 22/11/2019
Written by BCCD734B40E887BB8768FB1C64C2F54478E7797D4D317CFD9B6E33C4369D6F14
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1824763080003187046
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1824811959499276368
- noteId - 1824811959499276368
- participantId -
- noteAuthorParticipantId - BCCD734B40E887BB8768FB1C64C2F54478E7797D4D317CFD9B6E33C4369D6F14 Participant Details
- createdAtMillis - 1723904049169
- tweetId - 1824763080003187046
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 1
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Contexto: Harris promete quitarles las patentes a las compañías farmacéuticas que recibieron fondos federales para I+D de un medicamento protegido por patente y se niegen a reducir su precio en Estados Unidos. https://www.c-span.org/video/?466668-1/kamala-harris-meets-voters-muscatine-iowa el 22/11/2019
Note Ratings
| rated at | rated by | |
| 2024-08-18 15:05:19 -0500 | Rating Details | |
| 2024-08-18 13:49:55 -0500 | Rating Details | |
| 2024-08-18 08:43:52 -0500 | Rating Details | |
| 2024-08-18 07:11:31 -0500 | Rating Details | |
| 2024-08-18 04:18:15 -0500 | Rating Details | |
| 2024-08-18 04:04:30 -0500 | Rating Details | |
| 2024-08-18 01:21:31 -0500 | Rating Details | |
| 2024-08-17 23:43:22 -0500 | Rating Details | |
| 2024-08-17 21:39:22 -0500 | Rating Details | |
| 2024-08-17 20:46:10 -0500 | Rating Details | |
| 2024-08-17 20:45:41 -0500 | Rating Details | |
| 2024-08-17 20:45:38 -0500 | Rating Details | |
| 2024-08-17 20:29:58 -0500 | Rating Details | |
| 2024-08-17 18:36:04 -0500 | Rating Details | |
| 2024-08-17 18:04:53 -0500 | Rating Details | |
| 2024-08-17 17:13:33 -0500 | Rating Details | |
| 2024-08-17 14:56:12 -0500 | Rating Details | |
| 2024-08-17 13:38:13 -0500 | Rating Details | |
| 2024-08-17 12:52:43 -0500 | Rating Details | |
| 2024-08-17 12:51:55 -0500 | Rating Details | |
| 2024-08-17 12:40:56 -0500 | Rating Details | |
| 2024-08-17 12:26:28 -0500 | Rating Details | |
| 2024-08-17 12:20:57 -0500 | Rating Details | |
| 2024-08-17 11:07:28 -0500 | Rating Details | |
| 2024-08-17 11:02:30 -0500 | Rating Details | |
| 2024-08-17 10:41:33 -0500 | Rating Details | |
| 2024-08-17 10:34:00 -0500 | Rating Details | |
| 2024-08-17 10:23:31 -0500 | Rating Details | |
| 2024-08-17 10:16:37 -0500 | Rating Details | |
| 2024-08-17 10:05:42 -0500 | Rating Details | |
| 2024-08-17 10:03:44 -0500 | Rating Details | |
| 2024-08-17 09:57:05 -0500 | Rating Details | |
| 2024-08-18 16:33:58 -0500 | Rating Details | |
| 2024-08-18 11:27:47 -0500 | Rating Details | |
| 2024-08-17 20:05:47 -0500 | Rating Details | |
| 2024-08-17 19:06:19 -0500 | Rating Details | |
| 2024-08-17 19:04:14 -0500 | Rating Details | |
| 2024-08-17 17:35:37 -0500 | Rating Details | |
| 2024-08-17 14:54:50 -0500 | Rating Details | |
| 2024-08-17 12:10:53 -0500 | Rating Details | |
| 2024-08-17 11:27:15 -0500 | Rating Details | |
| 2024-08-17 09:59:55 -0500 | Rating Details |